Company / Shareholders' Equity
Lunai Bioworks Inc. Shareholders' Equity History
FY2011-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$1.5M
FY2017
5-year range
-$1.7M / $1.5M
FY2013-FY2017
Trend
+340.5%
vs FY2016
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shareholders' Equity changed +340% YoY in FY2017, a notable deviation from the 3-year average annual change of -6259%.
Based on SEC 10-K filings.
$2M in FY2017.
Improved from -$2M to $2M over the past 3 years.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2017, shareholders' equity increased 340.5% year-over-year.
Company context
Key Data Points
- Altman Z-Score -1.04 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2017 | $1.5M | +340.5% |
| FY2016 | -$637.4K | +62.2% |
| FY2014 | -$1.7M | -19180.7% |
| FY2011 | -$8.7K | - |
As of FY2017 · SEC 10-K · Updated Jun 24, 2026